Welcome to Cancer Registration etc


This is a repository of web-site links on cancer registration, national plans for cancer control and other relevant issues.

You may find useful links and information concerning the following countries and regions:

European Union countries: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Continue reading

Cancer registration in Greece updated

[Note: For a long time I have not updated this blog. However a recent article and some information made me active again.]

The latest news, concerning cancer registration in Greece, can be found in page 12 of the 1st Newsletter of the Hellenic Center of Disease Prevention & Control or HCDPC (issue No 1, year 1, April 6, 2011).

to find out more click here (directs to the relevant page)


web statistics

The first preparatory meeting for the European Partnership for Action Against Cancer

Last News (11 December 2009):

The first preparatory meeting for the European Partnership for Action Against Cancer


Brussels, 07-08 December 2009

Draft agenda (144 KB)
Summary report (50 KB)
List of participants (50 KB)

Joint Actions 2010 (265KB)
Executive Agency for Health and Consumers


Latest News – 3d ICC Congress

The 3d International Cancer Control Congress

Starting date: 8 November 2009, Closing date: 11 November 2009
Location: Cernobbio, Como, Italy
Host: FONDAZIONE IRCCS “Istituto Nazionale dei Tumori”, Milan under the patronage of “Regione Lombardia”, “Alleanza Contro il Cancro” and “Ministero del Lavoro, Salute e Politiche Sociali”, Italy and the Co-Sponsorship of W.H.O.

Congress Purpose
The purpose of the 3rd International Cancer Control Congress is to promote and foster a global community of practice through enabling extensive participation and dialogue between countries and societies with wide and varying experiences in cancer control; building on and synergizing ongoing work by governments, NGOs, international organizations to make sustainable cancer control an important global priority.

Welcome Messages: http://www.meet-ics.com/cancercontrol2009/welcome.html

Dear all it is with great pleasure that  I announce that the Monography with papers describing  some of the studies that will be presented at the ICCC3 congress  next week is  already  online http://www.tumorionline.it/ Thank you for your attention. my best wishes,

Andrea Micheli

Descriptive Epidemiology and Health Planning Unit
Fondazione IRCCS “Istituto Nazionale dei Tumori”
Via Venezian, 1
20133 Milan, Italy
Tel 0039 02 23902867 / 3526
Fax 0039 02 23903528


web statistics

European Partnership for Action Against Cancer

The European Partnership for Action Against Cancer

The European Commission is reinforcing its long-term commitment to the fight against cancer by launching a European Partnership for Action Against Cancer. The overall aim of the Partnership, which is initially planned for 2009-2013, is to support Member States and other stakeholders in their efforts to tackle cancer more efficiently by providing a framework for identifying and sharing information, capacity and expertise in cancer prevention and control. It aims to engage a wide range of stakeholders across the EU in a collective effort and with a common commitment to addressing cancer. It will also help to avoid scatted actions and duplication of efforts, and contribute to better use of limited resources available.

By the end of the Partnership, the objective is for all Member States to have integrated cancer plans. The long-term aim set out by the Commission Communication is to reduce cancer by 15% by 2020.

Launch of the European Partnership for Action Against Cancer

On 8 September 2009, the European Commission is launching the European Partnership for Action Against Cancer.

This launch event of the European Partnership for Action Against Cancer will be opened by the President of the European Commission José Manuel Barroso and hosted by Health Commissioner Androulla Vassiliou. Personal messages will be heard from cancer patients and cancer survivors from across the European Union. There will be a panel discussion with Commissioners, politicians and experts about the way forward in the European fight against cancer. The event will close with a symbolic release of balloons (weather permitting). This half-day event will take place in Brussels on 8 September, starting at 9.30 am. For further information, please see the provisional programme.

To attend the launch, please register here (available shortly). Please register as soon as possible as the number of participants will be limited due to venue capacity.

More information …… (link)


web statistics

September-December 2008 news

Happy New Year to all

Please note: If you are a new visitor, you may prompt to the ABOUT page for more information about this site.


Latest News: January 2009

New developments in Greece in the field of Public Health: a series of 15 national action plans in the field of public health were presented by the Greek Ministry of Health & Social Solidarity on 17 December 2008.

The National Action Plans include:

a) a National Action Plan against Cancer 2008-2012 (download ~2.1 MB, in Greek only)

b) a National Action Plan against Smoking 2008-2012 (download ~1.6 MB, in Greek only) which is accompanied by new legislation “for the Protection of Youths from Tobacco and Alcohol”; law 3730/2008 published in the official journal of the Greek Government FEK A’ 262/23.12.2008, to take effect from 1st July 2009 (link, in Greek only)

c) a National Action Plan to Reduce the Harmful Effects of Alcohol Consumption on Health 2008-2012 (download ~1.4 MB, in Greek only)

d) a National Action Plan for Proper Nutrition and Nutritional Disorders 2008-2012 (download ~1.8 MB, in Greek only)

All the Public Health national action plans are available, in Greek only, at a dedicated web-page (link) of the “Health Map of Greece” web-site (link).


Please note: Visit the ” TRANSLATION Service” page of this site for help in translating text in your own language.

(last update: 9 Jan 2009)


web statistics

Some thoughts about the HPV-vaccine

Some thoughts about the HPV-vaccine

Within the small time period (5-6 years) of our knowledge, the vaccine seems to work well for the 4 HPV types (16, 18, 6, 11) and at present, it seems that it is not harmful for the individual.

On the other hand, there is a lot of uncertainty over its long-term effect and it is unknown whether it shall have all the argued positive results (a 70% decrease in cervical cancer incidence or so).

It is important to point out that we know very little about the HPV itself and it is also interesting that there are several variants of the HPV types, with differing health-risk patterns and with differing geographic distributions for each type (e.g. European, African, American and Asian variants for HPV 16 and 18). For example, a study showed that the risk of a subsequent CIN3 lesion was 3- fold greater for those women with the American than the European HPV-16 variant (*).

And this is the mystery. We don’t know the HPV’s role in the nature’s ecosystem and we don’t know what will be the nature’s response to a massive intervention to prevent a very common infection; since it is the persistent HPV infection that we want to fight with the vaccine and not cancer per se.

We cannot predict the future accurately and especially what will happen in 30-40 years time. Moreover, our current mathematical models may not be able yet to calculate all possible scenarios. For example, an unlikely but not impossible bad scenario would be that, after the implementation of the HPV-vaccine, the nature might “replace” them with some of the other oncogenic HPV types such as 53, 56 etc. (as happens with microbial populations when treated with antibiotics). In this case, the effect of vaccination would be almost negligible and all the scarce resources allocated to HPV-vaccination would have been wasted.

Certainly, the HPV-vaccine technology is very promising and probably it will provide future weapons for cancer control. However, a critical question is whether the taxpayers can afford now an expensive technology for an unknown future effect.

In addition to all the above, cervical cancer in Western Europe and in other developed countries is not such a major problem as compared with other countries where incidence and mortality are multifold (i.e. Mexico, Brazil etc.).

No doubt, cervical cancer for the individual is a major threat. The society however, has to balance its scarce resources and the huge funds, allocated for a vaccine that is still under study, might be more effective if used in other areas of disease prevention (e.g. improvement of the current cervical cancer screening programs, the prevention of heart disease or of car accidents etc.).

In my view, the reaction of several “western” governments to implement the HPV-vaccine was rather premature and certainly they could have waited for a few years until more knowledge transpires (at least until solving the question of a boost dose). Nevertheless, the way the HPV-vaccine was announced, licensed and rolled-out created an irreversible demand.

But wait. In 30-40 years time we shall learn the truth.

(*) “Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18“, Long Fu Xi, Koutsky Laura A., Hildesheim Allan, Galloway Denise A., Wheeler Cosette M., Winer Rachel L., Ho Jesse, Kiviat Nancy B., Cancer epidemiology, biomarkers & prevention, vol. 16, no1, pp. 4-10, January 1, 2007.

(Abstract: http://cebp.aacrjournals.org/cgi/content/abstract/16/1/4, and free full text access/ last visit 12 June 2008).
art. added Apr. 2010: “Abnormal Pap tests after the HPV vaccine“, Heley S, Brotherton J., Aust Fam Physician. 2009 Dec;38(12):977-9. (Abstract, free full text , access/ last visit 10 April 2010)

web statistics